Table 3.
Pearson Rank correlation of FGF19, FGF21, FGF23, and fetuin-A with anthropometric and blood biochemical variables.
| FGF-19 | FGF-21 | FGF-23 | Fetuin-A | |||||
|---|---|---|---|---|---|---|---|---|
| Pearson correlation | r | p | r | p | r | p | r | p |
| FGF-19 | 1.000 | 0.079 | 0.741 | 0.301 | 0.185 | −0.016 | 0.944 | |
| FGF-21 | 0.079 | 0.741 | 1.000 | 0.456* | 0.043 | −0.152 | 0.521 | |
| FGF-23 | 0.301 | 0.185 | 0.456* | 0.043 | 1.000 | −0.089 | 0.700 | |
| Fetuin-A | −0.016 | 0.944 | −0.152 | 0.521 | −0.089 | 0.700 | 1.000 | |
| age | −0.035 | 0.879 | 0.118 | 0.621 | −0.196 | 0.395 | 0.319 | 0.159 |
| Height | −0.224 | 0.329 | 0.110 | 0.646 | 0.186 | 0.419 | 0.016 | 0.945 |
| Weight | −0.278 | 0.223 | −0.188 | 0.427 | 0.128 | 0.581 | 0.473* | 0.030 |
| BMI | −0.213 | 0.353 | −0.227 | 0.336 | 0.065 | 0.780 | 0.521* | 0.015 |
| Waist | −0.295 | 0.195 | −0.144 | 0.543 | 0.031 | 0.893 | 0.430 | 0.052 |
| Hip | −0.433* | 0.050 | −0.103 | 0.665 | −0.009 | 0.969 | 0.454* | 0.039 |
| WHR | 0.128 | 0.580 | −0.158 | 0.506 | 0.127 | 0.582 | 0.138 | 0.551 |
| SBP | −0.013 | 0.954 | 0.340 | 0.143 | 0.057 | 0.806 | 0.183 | 0.428 |
| DBP | −0.367 | 0.102 | 0.487* | 0.030 | 0.272 | 0.233 | 0.383 | 0.087 |
| PG | 0.296 | 0.193 | −0.158 | 0.505 | −0.252 | 0.270 | 0.478* | 0.028 |
| Insulin | 0.019 | 0.935 | −0.178 | 0.453 | 0.249 | 0.277 | 0.571** | 0.007 |
| HOMA-IR | 0.059 | 0.798 | −0.185 | 0.436 | 0.171 | 0.460 | 0.616** | 0.003 |
| M-value | 0.248 | 0.279 | −0.158 | 0.505 | −0.240 | 0.295 | −0.303 | 0.182 |
| NEFA | −0.138 | 0.550 | −0.056 | 0.813 | −0.425 | 0.055 | −0.257 | 0.261 |
| TCH | −0.291 | 0.200 | 0.009 | 0.971 | −0.478* | 0.028 | −0.176 | 0.444 |
| Testosterone | 0.071 | 0.759 | −0.250 | 0.288 | 0.536* | 0.012 | 0.231 | 0.314 |
| FAI | −0.190 | 0.408 | −0.410 | 0.072 | 0.222 | 0.334 | 0.375 | 0.094 |
| SHBG | 0.406 | 0.068 | 0.487* | 0.030 | 0.008 | 0.971 | −0.286 | 0.210 |
| LH | −0.248 | 0.292 | 0.182 | 0.456 | 0.264 | 0.261 | 0.029 | 0.902 |
| FSH | 0.157 | 0.509 | 0.036 | 0.883 | −0.208 | 0.379 | 0.445* | 0.049 |
| Estradiol | −0.297 | 0.203 | −0.082 | 0.739 | 0.364 | 0.114 | −0.081 | 0.735 |
| TG | −0.240 | 0.295 | 0.054 | 0.820 | −0.220 | 0.338 | 0.010 | 0.967 |
| HDL | −0.193 | 0.403 | −0.170 | 0.473 | −0.487* | 0.025 | −0.296 | 0.192 |
| LDL | −0.164 | 0.478 | 0.212 | 0.370 | 0.275 | 0.228 | 0.024 | 0.919 |
| ALT | −0.190 | 0.423 | −0.266 | 0.271 | 0.010 | 0.968 | 0.235 | 0.319 |
| HbA1c | −0.153 | 0.532 | −0.047 | 0.854 | −0.296 | 0.219 | 0.339 | 0.155 |
| Prolactin | 0.272 | 0.259 | −0.309 | 0.212 | 0.122 | 0.620 | −0.162 | 0.507 |
| TSH | −0.029 | 0.902 | −0.015 | 0.949 | 0.163 | 0.479 | −0.079 | 0.732 |
| DHEAS | 0.130 | 0.596 | −0.184 | 0.466 | 0.311 | 0.194 | −0.381 | 0.108 |
| Androsterone | −0.162 | 0.508 | −0.346 | 0.159 | 0.235 | 0.332 | −0.283 | 0.241 |
p is the two tailed significance and r is Pearson correlation coefficient. FGF19, fibroblast growth factor 19; FGF21, fibroblast growth factor 21; FGF23, fibroblast growth factor 23; BMI, Body mass index; WHR, Waist to hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; PG, Plasma glucose; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; M-value, Insulin sensitivity index; NEFA, non-esterified fatty acid; TCH, Total cholesterol; FAI, Free androgen index; SHBG, Sex hormone-binding globulin; LH, Luteinizing hormone; FSH, Follicle stimulating hormone; TG, Triglycerides; HDL, High density lipoprotein; LDL, Low density lipoprotein; ALT, Alanine transaminase; HbA1c, hemoglobin A1c; TSH, Thyroid stimulating hormone; DHEAS, Dehydroepiandrosterone.